Loading…
Loading…
Tender Value
Refer Docs
Closing Date
31 Aug 2026, 3:00 pm4d left
Managing director, UPMSCL
Managing director, UPMSCL
e-TENDER FOR THE SUPPLY OF DRUGS TO UTTAR PRADESH MEDICAL SUPPLIES CORPORATION LIMITED
2026_UMSCL_1175974_1
UPMSCL/Drugs-266/16
Open Tender
Medicines
Item Rate
SUDA Bhawan, 7/23, Sector-7, Gomti Nagar Extension
Please refer Tender documents.
2 documents required · 2 mandatory
₹5,900
Yes
Managing Director
Yes
SUDA Bhawan, 7/23, Sector-7, Gomti Nagar Extension
10 Aug 2026
10 Aug 2026
31 Aug 2026
10 Aug 2026
31 Aug 2026
10 Aug 2026
17 Aug 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1.01 | AMIODARONE HYDROCHLORIDE :- 50 mg/ml. : 3ml (Inj) Ampoule | 1 | Nos | - | - |
| 1.02 | Aspirin Gastro Resistant Tab IP 75 mg 1*10 per strip | 1 | Nos | - | - |
| 1.03 | ASPIRIN UNCOATED TABLET 325 mg 1*10 PER STRIP | 1 | Nos | - | - |
| 1.04 | ATROPINE SULPHATE OPHTHALMIC SOLUTION : 1% 5 ML FFS or BFS EYE DROP | 1 | Nos | - | - |
| 1.05 | Carboxymethyl cellulose sodium eye drop 1% w/v 10ml FFS green/amber color vial | 1 | Nos | - | - |
| 1.06 | Diltiazem hydrochloride injection 5 mg/ml 5ml vial | 1 | Nos | - | - |
| 1.07 | FENTANYL CITRATE INJECTION 50 mcg/ml - 2ml VIAL | 1 | Nos | - | - |
| 1.08 | FRAMYCETIN SULPHATE : 1% w/w 30gm (Cream) | 1 | Nos | - | - |
| 1.09 | HALOPERIDOL LACTATE : IP - 5mg/ml : 1ml (Inj) Ampoule | 1 | Nos | - | - |
| 1.1 | Homatropine hydrobromide drops 2% w/v, 5ml FFS or BFS eye drop | 1 | Nos | - | - |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.52 MB
tenderdocument266.pdf
Tender Documents • 1.59 MB
BOQ_2209978.xls
BOQ • 0.26 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].